26
|
Anonychuk A, Adeli K, Kinniburgh D, Santiago J, Tricco A. The value of in vitro diagnostics to improvement in patient outcomes and to the Canadian health care system: A focus on cardiovascular disease. Clin Biochem 2012. [DOI: 10.1016/j.clinbiochem.2012.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
27
|
Camacho C, Santiago J, Velazquez V, Gonzalez M, Sepulveda A, Ramos J. Helicobacter Pylori, A Protective Agent For Asthma Or Not? J Allergy Clin Immunol 2012. [DOI: 10.1016/j.jaci.2011.12.887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
28
|
Duarte JA, Macoto E, Santiago J, Garcia LB, Gregorio LC. Applicability of Questionnaire in Outcome in Rhinoplasty. Otolaryngol Head Neck Surg 2011. [DOI: 10.1177/0194599811415823a6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Objective: Evaluate the satisfaction and the actual benefit if rhinoplastic surgery, using questionnaires that assess since aspects related to appearance and function, even aspects of social order and compare them. Method: In a cross-sectional study of 105 patients who underwent rhinoplasty, the patients answered 2 questionnaires, the GBI (Glasgow Benefit Inventory) and the SNOT-22 (sino-nasal outcome test-22). Student t test was used to compare the SNOT-22 scores before and after surgery and Pearson correlation coefficient between SNOT-22 and GBI scores. Results: These 49 patients could be reached by telephone these 21 were men (42.85%), with a mean age of 28.96 years. The SNOT-22 were on average 17.41 points preoperatively and 13.63 in the postoperative. The results of the GBI in the postoperative period were 31.69 points on average. Conclusion: There was a high satisfaction rate of patients undergoing rhinoplasty when assessed through questionnaires GBI and SNOT-22 separately, but a weak correlation between them.
Collapse
|
29
|
Kunze R, Witt S, Vienken J, Rie K, Masayoshi N, Aritoshi K, Yoshinaga O, Yukiko H, Takahiro K, Hiroshi N, Takeshi N, Aoki S, Makino J, Noguchi M, Yamasaki F, Toda S, Santiago J, Caparros G, Vozmediano C, Molina F, Javier L, Sara A, Minerva A, Romera A, Kihm L, Diekmann C, Seckinger J, Sommerer C, Morath C, Zeier M, Schwenger V, Teixeira L, Rodrigues A, Carvalho MJ, Cabrita A, Mendonca D. Peritoneal dialysis. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
30
|
Zárraga-Galindo N, Vergara-Aragón P, Rosales-Meléndez S, Ibarra-Guerrero P, Domínguez-Marrufo LE, Oviedo-García RE, Hernández-Ramírez H, Hernández-Téllez B, López-Martínez IE, Sánchez-Cervantes I, Vázquez-García M, Santiago J. Effects of bee products on pentylenetetrazole-induced seizures in the rat. PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY 2011; 54:33-40. [PMID: 22423578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Bee products (BP) have been used for centuries as a diet complement with claimed curative properties. The aim of this study was to determine whether oral administration of BP prevented behavioral, histological, and biochemical alterations, caused by pentylenetetrazole (PTZ)-induced kindling in rats. Male Wistar rats were employed to evaluate seizure latency, number and duration, performance in the open field test, histological alterations and mortality following BP administration. Oral administration of BP at two doses, 30 and 60 mg/kg/day, significantly lengthened latency of both clonic and tonic PTZ-induced seizures, decreased the duration and frequency of seizures and reduced mortality. In the Open Field test, BP treated groups showed increases in the number of crossed squares and rearing counts, and on optimal dose, decreases in fecal boli. Histological analysis showed in PTZ (50 and 80 mg/kg) kindling rats, lungs with inflammatory peribronchiolar, and perialveolar infiltrates. In the liver, mild losses of trabeculae, multi-vesiculated hepatocytes (steatosis) and inflammatory infiltrates in hepatic parenchyma were observed. Interestingly, in the heart, fibers were markedly separated. In testis, stratified epithelium of seminal tubules lost its normal structure, tubules had epithelium loss, spermatids were absent, and spermatogonia and Leydig cells diminished. In PTZ kindling rats treated with BP, the lungs had no inflammatory infiltrates, although the heart showed some inflammatory infiltrates. Remaining structures had normal characteristics. These results, suggest that BP can protect rats from effects of PTZ-induced kindling.
Collapse
|
31
|
Santiago J, Muszlak M, Goulois E, Ranaivoarivony V, Hébert JC, Lacombe D, Verloes A. Syndrome de Kabuki en milieu tropical chez un nourrisson hospitalisé pour diarrhée et stagnation pondérale. Arch Pediatr 2010; 17:588-93. [DOI: 10.1016/j.arcped.2009.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2009] [Revised: 12/08/2009] [Accepted: 12/22/2009] [Indexed: 10/19/2022]
|
32
|
Nath P, Nelson B, Davoudiasl H, Dutta B, Feldman D, Liu Z, Han T, Langacker P, Mohapatra R, Valle J, Pilaftsis A, Zerwas D, AbdusSalam S, Adam-Bourdarios C, Aguilar-Saavedra J, Allanach B, Altunkaynak B, Anchordoqui LA, Baer H, Bajc B, Buchmueller O, Carena M, Cavanaugh R, Chang S, Choi K, Csáki C, Dawson S, de Campos F, De Roeck A, Dührssen M, Éboli O, Ellis J, Flächer H, Goldberg H, Grimus W, Haisch U, Heinemeyer S, Hirsch M, Holmes M, Ibrahim T, Isidori G, Kane G, Kong K, Lafaye R, Landsberg G, Lavoura L, Lee JS, Lee SJ, Lisanti M, Lüst D, Magro M, Mahbubani R, Malinsky M, Maltoni F, Morisi S, Mühlleitner M, Mukhopadhyaya B, Neubert M, Olive K, Perez G, Pérez PF, Plehn T, Pontón E, Porod W, Quevedo F, Rauch M, Restrepo D, Rizzo T, Romão J, Ronga F, Santiago J, Schechter J, Senjanović G, Shao J, Spira M, Stieberger S, Sullivan Z, Tait TM, Tata X, Taylor T, Toharia M, Wacker J, Wagner C, Wang LT, Weiglein G, Zeppenfeld D, Zurek K. The Hunt for New Physics at the Large Hadron Collider. ACTA ACUST UNITED AC 2010. [DOI: 10.1016/j.nuclphysbps.2010.03.001] [Citation(s) in RCA: 100] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Eron J, Livrozet JM, Morlat P, Lazzarin A, Katlama C, Hawkins T, Fujiwara T, Cuffe R, Vavro C, Santiago J, Ait-Khaled M, Min S, Yeo JM. Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961). J Int AIDS Soc 2010. [PMCID: PMC3112867 DOI: 10.1186/1758-2652-13-s4-o51] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
34
|
Schiff M, Benoist JF, Cardoso ML, Elmaleh-Bergès M, Forey P, Santiago J, Ogier de Baulny H. Early-onset hyperargininaemia: a severe disorder? J Inherit Metab Dis 2009; 32 Suppl 1:S175-8. [PMID: 19381865 DOI: 10.1007/s10545-009-1137-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/10/2009] [Revised: 03/09/2009] [Accepted: 03/17/2009] [Indexed: 10/20/2022]
Abstract
UNLABELLED Hyperargininaemia is a rare inborn error of metabolism due to a defect in the final step of the urea cycle. Infantile onset is the most common presentation with recurrent vomiting and psychomotor delay associated with spastic paraparesis; chronic hyperammonaemia is often overlooked. Neonatal and early-onset presentations are very uncommon and their clinical course not well-described. We report on a 3-week-old hyperargininaemic girl who presented with neurological deterioration associated with liver failure and 47-day ammonia intoxication before diagnosis could be made and treatment started. Despite appropriate but delayed treatment, our patient exhibited severe psychomotor delay at age 1 year. CONCLUSION Early identification and management of this rare but potentially treatable affection is crucial as delayed management may result in poor neurological outcome.
Collapse
|
35
|
Molina-Garrido M, Guillen-Ponce C, Santiago J, Muñoz M, Olaverri A, Haro L, Carrato A. Barber test as a screening tool in multidimensional geriatric evaluation in elderly women with early breast cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e20645] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e20645 Background: The Comprehensive Geriatric Assessment (CGA) is a key component of the treatment approach for older cancer patients, but it is time consuming. In this study, we have evaluated the validity of a brief frailty screening tool, the Barber test (BT), for identifying disability in older patients with early breast cancer (BC) in the University General Hospital in Elche. Methods: Between January 2007 and December 2007, a total of 41 patients older than 65 years who were actively receiving chemotherapy for early BC, were enrolled in our study. Eligible patients were screened with the Barber test and completed a standardized CGA (Activities of Daily Living measured by Barthel Scale, Instrumental Activities of Daily Living measured by Lawton-Brody Scale, cognitive evaluation measured by Pfeiffer Test, comorbidity (Charlson´s index), risk of malnutrition (Nutritive Initiative Screening), and ECOG). The validity of the BT in this population was assessed by comparing the BT results with results from a simultaneous CGA. A receiver operating characteristic (ROC) analysis was employed. The ROC evaluated the BT as a screening measure for impairment compared with the CGA (using the definition of impairment on the CGA as deficits on ≥2 individual tests within the battery, and on the BT as a score >0). The area under the ROC curve (AUC) was calculated to reflect the predictive value of the BT for identifying impairment. Results: Forty-one women were recruited. Median age was 72.88 years (range 65.03 to 85.46). 30 patients (73.2%) were older than 70 years. 36.6% were dependent in Barthel Scale, and 46,3% were dependent in Lawton-Brody Scale. 19,5% had cognitive impairment. The Barber test was moderate predictive for identifying impairment compared with the CGA, with an AUC of 0.730 (standard error, 0.081; 95% confidence interval for detecting asymptomatic normals, 0.571–0.889); p=0.012). Conclusions: Functional impairments are prevalent among older patients with early BC who receive adjuvant chemotherapy treatment. The current results indicate that the brief Barber test performed nearly as well as a conventional CGA in detecting geriatric impairment in this population. No significant financial relationships to disclose.
Collapse
|
36
|
McNeal CJ, Wilson DP, Christou D, Bush RL, Shepherd LG, Santiago J, Wu GY. The use of surrogate vascular markers in youth at risk for premature cardiovascular disease. J Pediatr Endocrinol Metab 2009; 22:195-211. [PMID: 19492575 DOI: 10.1515/jpem.2009.22.3.195] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Premature cardiovascular disease (CVD) begins in youth--a crucial period when modification of the disease may have the greatest impact. Failure to diagnose preclinical CVD at this stage misses a major opportunity to prevent the long-term consequences of this disease. An array of surrogate vascular markers (SVMs) are now available that can determine the extent of preclinical vascular injury in the pediatric population. These SVMs include flow-mediated vasodilatation, carotid intima media thickness, arterial stiffness, and biomarkers including high sensitivity C-reactive protein, cell adhesion molecules and methylarginines. We believe that the use of these SVMs will help to develop a better understanding of early pathological vascular changes in youth, facilitate earlier diagnosis of preclinical atherosclerosis and provide an objective measure of the vascular effects of any therapeutic intervention aimed at risk factor modification. Ultimately, our future health will depend on carefully balancing the benefits of early diagnosis and treatment in high-risk youth with the long-term risk of CVD. The application of SVMs in the pediatric population will help us achieve this balance.
Collapse
|
37
|
Santiago J, Muszlak M, Samson C, Goulois E, Glorion A, Atale A, Ranaivoarivony V, Hebert JC, Bouvier R, Cordier MP. [Malignancy risk and Wiedemann-Beckwith syndrome: what follow-up to provide?]. Arch Pediatr 2008; 15:1498-502. [PMID: 18674889 DOI: 10.1016/j.arcped.2008.06.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2008] [Revised: 06/02/2008] [Accepted: 06/17/2008] [Indexed: 12/21/2022]
Abstract
Wiedemann-Beckwith syndrome (WBS) is a syndrome of excessive growing with a high predisposition to developing embryologic tumours within the first years of life. This risk is evaluated between 7.5 and 10%; it varies with the mechanisms of mutations involved. These take place in two distinct domains of 11p15, which are under parental printing. Emerging techniques of cytogenetic and molecular biology now have shown correlations between genotypes and phenotypes, and can identify the 30% of WBS who are especially at risk of developing tumours. A specific follow-up, integrating the specificity of developing tumours of each 11p15 mutations involved, is now proposed to patients with WBS.
Collapse
|
38
|
Santiago J, Hernández-Cruz JL, Manjarrez-Zavala ME, Montes-Vizuet R, Rosete-Olvera DP, Tapia-Díaz AM, Zepeda-Peney H, Terán LM. Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma. Eur Respir J 2008; 32:1243-9. [PMID: 18579545 DOI: 10.1183/09031936.00085107] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Macrophages play a crucial role in respiratory viral infections. However, the mechanisms by which these cells are recruited locally are not fully understood. The current authors studied the role of the chemokines monocyte chemotactic protein (MCP)-1, -2, -3 and -4 on monocyte/macrophage recruitment during respiratory viral infections. Levels of these chemokines were investigated in nasal aspirates from 6-12-yr-old children suffering from respiratory viral infections, caused by rhinoviruses, influenza viruses, parainfluenza viruses, adenoviruses and respiratory syncytial virus. MCP-3 and -4 were significantly higher in samples derived from virus-infected children compared with samples from the same children when they had been asymptomatic. Concentrations of both chemokines were found to significantly correlate with the number of recruited nasal macrophages. Chemotaxis assays showed that purified MCP-3 and -4 from nasal aspirates showed biological activity in vitro. There were no significant differences in MCP-1 and -2 levels between both groups. The present data indicates that monocyte chemotactic protein-3 and -4 may have an important role in macrophage recruitment in children with proven upper respiratory viral infections. These chemokines could be potential targets for therapeutic intervention in respiratory viral infections.
Collapse
|
39
|
DeSalvo D, Pohl JF, Wilson DP, Bryant W, Easley D, Greene J, Santiago J. Cholestasis Secondary to Panhypopituitarism in an Infant. J Natl Med Assoc 2008; 100:342-4. [DOI: 10.1016/s0027-9684(15)31249-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
40
|
Muszlak M, Lartigau-Roussin C, Farthouat L, Petinelli M, Hebert JC, Santiago J. Vaccination de l'enfant contre l'hépatite B à Mayotte, île française des Comores. Arch Pediatr 2007; 14:1132-6. [PMID: 17566719 DOI: 10.1016/j.arcped.2007.05.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2006] [Revised: 04/13/2007] [Accepted: 05/07/2007] [Indexed: 11/20/2022]
Abstract
Hepatitis B virus (HBV) is responsible for a worldwide mortality of 1 million people each year. It constitutes a major public health problem, especially in highly endemic zones, where it concerns the youngest children, primarily by a mother to child transmission, with a strong risk of chronic hepatitis infection and hepatocellular carcinoma. Immunisation of children versus HBV is known to be efficient and safe. In Mayotte, a French overseas territory in Indian Ocean, immunisation versus HBV has been introduced since 1993 in the vaccine schedule, starting at day 1 of life. We report hereby the local experience and practice on HBV infection, state of vaccine coverage, and difficulties met with this major public health issue.
Collapse
|
41
|
Muszlak M, Chapgier A, Barry Harivelo R, Castella C, Crémades F, Goulois E, Laporte R, Casanova JL, Ranaivoarivony V, Hebert JC, Santiago J, Picard C. [Multifocal infection due to Mycobacterium intracellulare: first case of interferon gamma receptor partial dominant deficiency in tropical French territory]. Arch Pediatr 2007; 14:270-2. [PMID: 17223023 DOI: 10.1016/j.arcped.2006.11.023] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2006] [Accepted: 11/30/2006] [Indexed: 11/23/2022]
Abstract
Nontuberculous mycobacterial infections are rare in immunocompetent children, and usually present as adenitis. We report a case of a 6-year-old girl with a multifocal chronic osteomyelitis and pulmonary localisation due to Mycobacterium intracellulare associated with an autosomal dominant mutation of interferon gamma receptor 1 gene (INFGR1) leading to a syndrome of mendelian predisposition to mycobacteria infections by partial deficiency of intracellular signalisation of gamma interferon. This child has been cured with anti-mycobacteria drugs and gamma interferon. This report focus on the importance of looking for a susceptibility of the host to infectious diseases, which can lead to a specific treatment. As far as we know, this is the first case described in a tropical area.
Collapse
|
42
|
Santiago FM, Santaella JI, Santiago J, Garzón A, Molina M, De La Linde C. [Metallic dental prosthesis caught in the larynx]. REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION 2007; 54:66. [PMID: 17319443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
|
43
|
Machtay M, Scherpereel A, Santiago J, Lee J, McDonough J, Kinniry P, Arguiri E, Shuvaev V, Sun J, Cengel K, Solomides C, Christofidou-Solomidou M. Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse. Radiother Oncol 2006; 81:196-205. [PMID: 17069914 PMCID: PMC1764603 DOI: 10.1016/j.radonc.2006.09.013] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2006] [Revised: 09/04/2006] [Accepted: 09/22/2006] [Indexed: 12/22/2022]
Abstract
PURPOSE Since oxidative injury is implicated in radiation-induced tissue damage to the lung, we studied systemically administered polyethylene glycol (PEGylated) antioxidant enzymes (AOEs) as pulmonary radioprotectors in mice. METHODS AND MATERIALS C57/bl6 Mice received 13.5 Gy single-dose irradiation to the thorax. One cohort also received 100 microg of a 1:1 mixture of PEG-AOEs {PEG-catalase and PEG-superoxide dismutase (SOD)} intravenously, pre-irradiation and subgroups were evaluated at variable time-points for inflammation and fibrosis. Potential for AOE tumor protection was studied by thoracic irradiation of mice with Lewis lung carcinoma. RESULTS At 48 h post-irradiation, control irradiated mice had marked elevations of tissue p21, Bax and TGF-beta1 in lungs, not seen in irradiated, PEG-AOE-treated mice. TUNEL staining of lung sections was performed at just one time-point (24 h post-irradiation) and revealed a decrease in apoptotic cells with AOE treatment. At four months post-irradiation, these mice had significantly increased pulmonary fibrosis as measured by hydroxyproline content. Mice treated with PEG-AOE prior to irradiation had 4-month hydroxyproline levels that were similar to that of unirradiated controls (p = 0.28). This corresponded to less pulmonary fibrosis as visualized histologically when compared with mice irradiated without AOEs. PEG-AOEs did not prevent post-irradiation pulmonary inflammation or lung cancer response to irradiation. CONCLUSIONS A mixture of PEG-SOD and PEG-CAT successfully diminished radiation pulmonary fibrosis in mice. There was also a corresponding effect on several early biomarkers of lung injury and decreased apoptosis. There were no significant effects on acute pneumonitis or tumor protection.
Collapse
|
44
|
Machtay M, Scherpereel A, Santiago J, Lee J, McDonough J, Kinniry P, Arguiri E, Shuvaev V, Sun J, Cengel K, Solomides C, Christofidou-Solomidou M. Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse. Radiother Oncol 2006. [PMID: 17069914 PMCID: PMC1764603 DOI: 10.1016/j.radonc.2006.09.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/15/2023]
Abstract
PURPOSE Since oxidative injury is implicated in radiation-induced tissue damage to the lung, we studied systemically administered polyethylene glycol (PEGylated) antioxidant enzymes (AOEs) as pulmonary radioprotectors in mice. METHODS AND MATERIALS C57/bl6 Mice received 13.5 Gy single-dose irradiation to the thorax. One cohort also received 100 microg of a 1:1 mixture of PEG-AOEs {PEG-catalase and PEG-superoxide dismutase (SOD)} intravenously, pre-irradiation and subgroups were evaluated at variable time-points for inflammation and fibrosis. Potential for AOE tumor protection was studied by thoracic irradiation of mice with Lewis lung carcinoma. RESULTS At 48 h post-irradiation, control irradiated mice had marked elevations of tissue p21, Bax and TGF-beta1 in lungs, not seen in irradiated, PEG-AOE-treated mice. TUNEL staining of lung sections was performed at just one time-point (24 h post-irradiation) and revealed a decrease in apoptotic cells with AOE treatment. At four months post-irradiation, these mice had significantly increased pulmonary fibrosis as measured by hydroxyproline content. Mice treated with PEG-AOE prior to irradiation had 4-month hydroxyproline levels that were similar to that of unirradiated controls (p = 0.28). This corresponded to less pulmonary fibrosis as visualized histologically when compared with mice irradiated without AOEs. PEG-AOEs did not prevent post-irradiation pulmonary inflammation or lung cancer response to irradiation. CONCLUSIONS A mixture of PEG-SOD and PEG-CAT successfully diminished radiation pulmonary fibrosis in mice. There was also a corresponding effect on several early biomarkers of lung injury and decreased apoptosis. There were no significant effects on acute pneumonitis or tumor protection.
Collapse
|
45
|
Balogh GA, Mailo DA, Corte MM, Roncoroni P, Nardi H, Vincent E, Martinez D, Cafasso ME, Frizza A, Ponce G, Vincent E, Barutta E, Lizarraga P, Lizarraga G, Monti C, Paolillo E, Vincent R, Quatroquio R, Grimi C, Maturi H, Aimale M, Spinsanti C, Montero H, Santiago J, Shulman L, Rivadulla M, Machiavelli M, Salum G, Cuevas MA, Picolini J, Gentili A, Gentili R, Mordoh J. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer. Int J Oncol 2006; 28:995-1002. [PMID: 16525651 DOI: 10.3892/ijo.28.4.995] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
p53 wild-type is a tumor suppressor gene involved in DNA gene transcription or DNA repair mechanisms. When damage to DNA is unrepairable, p53 induces programmed cell death (apoptosis). The mutant p53 gene is the most frequent molecular alteration in human cancer, including breast cancer. Here, we analyzed the genetic alterations in p53 oncogene expression in 55 patients with breast cancer at different stages and in 8 normal women. We measured by ELISA assay the serum levels of p53 mutant protein and p53 antibodies. Immunohistochemistry and RT-PCR using specific p53 primers as well as mutation detection by DNA sequencing were also evaluated in breast tumor tissue. Serological p53 antibody analysis detected 0/8 (0%), 0/4 (0%) and 9/55 (16.36%) positive cases in normal women, in patients with benign breast disease and in breast carcinoma, respectively. We found positive p53 mutant in the sera of 0/8 (0.0%) normal women, 0/4 (0%) with benign breast disease and 29/55 (52.72%) with breast carcinoma. Immunohistochemistry evaluation was positive in 29/55 (52.73%) with mammary carcinoma and 0/4 (0%) with benign breast disease. A very good correlation between p53 mutant protein detected in serum and p53 accumulation by immunohistochemistry (83.3% positive in both assays) was found in this study. These data suggest that detection of mutated p53 could be a useful serological marker for diagnostic purposes.
Collapse
MESH Headings
- Adult
- Aged
- Aged, 80 and over
- Autoantibodies/blood
- Biomarkers, Tumor/blood
- Biomarkers, Tumor/genetics
- Biomarkers, Tumor/immunology
- Breast Neoplasms/blood
- Breast Neoplasms/genetics
- Breast Neoplasms/pathology
- Carcinoma in Situ/blood
- Carcinoma in Situ/genetics
- Carcinoma in Situ/pathology
- Carcinoma, Ductal, Breast/blood
- Carcinoma, Ductal, Breast/genetics
- Carcinoma, Ductal, Breast/pathology
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Immunohistochemistry/methods
- Middle Aged
- Mutation
- Neoplasm Staging
- Tumor Suppressor Protein p53/blood
- Tumor Suppressor Protein p53/genetics
- Tumor Suppressor Protein p53/immunology
Collapse
|
46
|
Lin B, Wang Z, Vora GJ, Thornton JA, Schnur JM, Thach DC, Blaney KM, Ligler AG, Malanoski AP, Santiago J, Walter EA, Agan BK, Metzgar D, Seto D, Daum LT, Kruzelock R, Rowley RK, Hanson EH, Tibbetts C, Stenger DA. Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays. Genes Dev 2006; 16:527-35. [PMID: 16481660 PMCID: PMC1457032 DOI: 10.1101/gr.4337206] [Citation(s) in RCA: 122] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2005] [Accepted: 12/22/2005] [Indexed: 11/24/2022]
Abstract
The exponential growth of pathogen nucleic acid sequences available in public domain databases has invited their direct use in pathogen detection, identification, and surveillance strategies. DNA microarray technology has offered the potential for the direct DNA sequence analysis of a broad spectrum of pathogens of interest. However, to achieve the practical attainment of this potential, numerous technical issues, especially nucleic acid amplification, probe specificity, and interpretation strategies of sequence detection, need to be addressed. In this report, we demonstrate an approach that combines the use of a custom-designed Affymetrix resequencing Respiratory Pathogen Microarray (RPM v.1) with methods for microbial nucleic acid enrichment, random nucleic acid amplification, and automated sequence similarity searching for broad-spectrum respiratory pathogen surveillance. Successful proof-of-concept experiments, utilizing clinical samples obtained from patients presenting adenovirus or influenza virus-induced febrile respiratory illness (FRI), demonstrate the ability of this approach for correct species- and strain-level identification with unambiguous statistical interpretation at clinically relevant sensitivity levels. Our results underscore the feasibility of using this approach to expedite the early surveillance of diseases, and provide new information on the incidence of multiple pathogens.
Collapse
|
47
|
Kuo YS, Schwartz B, Santiago J, Anderson PS, Fields AL, Goldberg GL. How often should a port-A-cath be flushed? Cancer Invest 2006; 23:582-5. [PMID: 16305984 DOI: 10.1080/07357900500276923] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
While it is important during treatment to flush the port-A-cath (PAC) with heparin regularly, catheter maintenance needs to be evaluated in those patients who, after completion of therapy, retained their ports for extended periods of time. The manufacturer has recommended monthly accession to maintain catheter patency and function. Our objective is to demonstrate that a longer interval between maintenance accessions of PACs still may be medically safe, convenient, and more efficient. We performed a retrospective review of all patients who had undergone PAC insertion from 1988 to 1993 at the Albert Einstein College of Medicine, and from 1997 to 2002 at the New York Hospital Medical Center of Queens. An adequate maintenance time is defined as a period of at least 6 months without chemotherapy or total parenteral nutrition. Data collected included date and location of PAC insertion, date of PAC accessions, PAC complications, and results of attempts at flushing the catheters with no venous blood return. All data were entered into an Excel spreadsheet and analyzed. The difference in interval accessions in patients without any complication to patients with complication was calculated using the Mann-Whitney "U" test. A total of 73 patients were included in the study. Compliance with visits for PAC maintenance varied considerably with the individual median accession times varying between 28 and 262 days with an overall median of 42 days. The individual means ranged from 29.5 to 244 days with an overall mean of 53.6 days. Seven patients in the group had episodes where the provider was unable to draw blood from the port during routine accession. The average intervals between accessions for each of these patients ranged from 38 to 244 days. The average intervals of accession among those patients who had no blood return during PAC accession was 79 days, versus 63 days for those without any difficulty. The difference was not statistically significant (p>0.05). Monthly maintenance of PAC is excessive, inconvenient for the patients, and expensive. Extending the interval of PAC maintenance proves to be medically safe and beneficial to the patients, the physicians and the health care system. Our clinical experience suggests that less frequent accessions of PACs is safe and feasible. We strongly advocate future prospective investigation of alternative PAC maintenance protocols in gynecologic cancer patients.
Collapse
|
48
|
Santiago FM, Santiago J, Prieto M, García-Sánchez MJ, Sánchez-Carríon JM, Martínez-Tellería A, Garzón A. [Dorsal epidural hematoma after implantation of a dorsal nerve stimulator]. REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION 2005; 52:440-1. [PMID: 16200928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
MESH Headings
- Adrenal Cortex Hormones/therapeutic use
- Anti-Inflammatory Agents/therapeutic use
- Anticoagulants/administration & dosage
- Anticoagulants/adverse effects
- Combined Modality Therapy
- Drainage
- Electric Stimulation Therapy
- Electrodes, Implanted/adverse effects
- Enoxaparin/administration & dosage
- Enoxaparin/adverse effects
- Hematoma, Epidural, Spinal/chemically induced
- Hematoma, Epidural, Spinal/complications
- Hematoma, Epidural, Spinal/drug therapy
- Hematoma, Epidural, Spinal/etiology
- Hematoma, Epidural, Spinal/surgery
- Humans
- Male
- Middle Aged
- Neuralgia/therapy
- Paraplegia/etiology
- Postoperative Complications/chemically induced
- Postoperative Complications/drug therapy
- Postoperative Complications/etiology
- Postoperative Complications/surgery
- Spinal Cord Compression/etiology
Collapse
|
49
|
Bostock P, Gregory R, Navarro I, Santiago J. Einstein gravity on the codimension 2 brane? PHYSICAL REVIEW LETTERS 2004; 92:221601. [PMID: 15245210 DOI: 10.1103/physrevlett.92.221601] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/26/2003] [Indexed: 05/24/2023]
Abstract
We look at general brane worlds in six-dimensional Einstein-Gauss-Bonnet gravity. We find the general matching conditions for the brane world, which remarkably give precisely the four-dimensional Einstein equations for the brane, even when the extra dimensions are noncompact and have infinite volume. Relaxing regularity of the curvature in the vicinity of the brane, or having a thick brane, gives rise to an additional term containing information on the brane's embedding in the bulk. We comment on the relevance of these results to a possible solution of the cosmological constant problem.
Collapse
|
50
|
Daum LT, Ye K, Chambers JP, Santiago J, Hickman JR, Barnes WJ, Kruzelock RP, Atchley DH. Comparison of TaqMan™ and Epoch Dark Quenchers™ during real-time reverse transcription PCR. Mol Cell Probes 2004; 18:207-9. [PMID: 15135457 DOI: 10.1016/j.mcp.2004.01.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2003] [Accepted: 01/29/2004] [Indexed: 11/21/2022]
Abstract
Several biotechnology companies have recently introduced novel quencher fluors for use with dual-labeled fluorogenic hydrolysis probes. The Epoch Dark Quencher trade mark fluorochrome consists of a non-fluorescent moiety capable of absorption at higher wavelengths (400-650 nm). The aim of this study was to: (1) evaluate the feasibility of using Epoch Dark Quencher fluorochromes in real-time PCR pathogen detection assays that were previously optimized with TaqMan (TAMRA) quenching fluors, and (2) compare the sensitivity based on cycle threshold (CT) between probes containing either TaqMan or Epoch Dark Quencher fluors. Our data indicate Epoch Dark Quencher probes can be used in place of TaqMan probes and their performance was not better than traditional TaqMan (TAMRA) quenchers. Marginal differences observed between quenching fluorochromes may arise from concentration differences during probe synthesis.
Collapse
|